Burosumab-twza Subcutaneous and Prolixin Decanoate
Determining the interaction of Burosumab-twza Subcutaneous and Prolixin Decanoate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: fluphenazine
Brand name: Permitil, Prolixin, Prolixin Decanoate, Prolixin Enanthate
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Prolixin Oral Concentrate
- Burosumab-twza Subcutaneous-Proloprim
- Burosumab-twza Subcutaneous-Promacot
- Burosumab-twza Subcutaneous-Promacot Injection, Intravenous
- Burosumab-twza Subcutaneous-Promacta
- Burosumab-twza Subcutaneous-Promacta (Eltrombopag Powder for Suspension)
- Prolixin Decanoate-Buspar
- Prolixin Decanoate-Buspar Dividose
- Prolixin Decanoate-Buspirone
- Prolixin Decanoate-Buspirone Hydrochloride
- Prolixin Decanoate-Busulfan
- Prolixin Decanoate-Busulfan Concentrate Injection